You are here

Policy update

Any changes to national or regional policies or legislation

Cancer Drugs Fund

sandy craine's picture
Submitted by sandy craine on Wed, 07/10/2015 - 9:58am

I said I would report back to our members on the NHS England meeting, held on the 7th September and on any subsequent activity taken by the coalitions of the patient organisations CML Support Group are members of.

The delay in my doing this is because it was widely expected that NHS England would publish details of the consultation on the ‘successor model’ to the Cancer Drugs Fund (CDF) the week following the NHS England meeting, and when that did not occur, the week after that.

TKI Discontinuation Criteria Established in Updated NCCN Guidelines

David Fitz's picture
Submitted by David Fitz on Wed, 27/03/2019 - 4:27pm

Latest NCCN guidelines for management of CML include protocols for TKI discontinuation. 

Article here:

https://www.onclive.com/conference-coverage/nccn-2019/tki-discontinuatio...

Updated guidelines here:

https://jnccn.org/downloadpdf/journals/jnccn/16/9/article-p1108.pdf

Government responds to Cancer Drugs Fund petition on blood cancer

sandy craine's picture
Submitted by sandy craine on Tue, 22/12/2015 - 3:03pm

As a member of the Blood Cancers Alliance (BCA), an informal coalition of charities representing the blood cancer community, Myeloma UK wrote an open letter to The Times newspaper on the Cancer Drugs Fund and the removal of blood cancer drugs from the list.